Guanze Medical Information Industry (Holding) Co., Ltd. and FUNDE (Hong Kong) Investment Holdings issued a clarification to their earlier Rule 3.5 takeover-related announcement, replacing the section on public float and listing status. They warned that the offer could leave the company with insufficient public float, potentially leading to a trading suspension, a “significant public float shortfall” marker, and possible delisting if compliance is not restored within 18 months. The company said it will seek a temporary waiver from the 25% public float requirement and that the offeror may place down or sell shares to independent third parties to restore public float, though no arrangements have been confirmed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guanze Intelligent Medical Information Industry Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260220-12026762), on February 20, 2026, and is solely responsible for the information contained therein.